Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic

Diabetologia

Volumn 57, Issue 6, 2014, Pages 1199-1203

  Tura, Andrea ^a   Muscelli, Elza ^b   Gastaldelli, Amalia ^c   Ferrannini, Ele ^b,c   Mari, Andrea ^a  

^a CNR   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Beta cell function; GIP; GLP 1; Glucose rate of appearance; Incretin effect; Insulin secretion; Mathematical model; Potentiation

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; BLOOD; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; THEORETICAL MODEL;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCRETINS; INSULIN; MALE; MIDDLE AGED; MODELS, THEORETICAL;

EID: 84901192849     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3219-7     Document Type: Article

References (19)

1. Vilsbøll T, Holst JJ (2004) Incretins, insulin secretion and type 2 diabetes mellitus. Diabetologia 47:357-366
2. Nauck MA, Homberger E, Siegel EG et al (1986) Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492-498
3. Muscelli E, Mari A, Casolaro A et al (2008) Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 57:1340-1348
4. Muscelli E, Mari A, Natali A et al (2006) Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 291:E1144-E1150
5. Campioni M, Toffolo G, Shuster LT, Service FJ, Rizza RA, Cobelli C (2007) Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study. Am J Physiol Endocrinol Metab 292:E54-E60
6. Burattini R, Morettini M (2012) Identification of an integrated mathematical model of standard oral glucose tolerance test for characterization of insulin potentiation in health. Comput Methods Prog Biomed 107:248-261
7. Jauslin PM, Silber HE, Frey N et al (2007) An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics. J Clin Pharmacol 47:1244-1255
8. Silber HE, Frey N, Karlsson MO (2010) An integrated glucose-insulin model to describe oral glucose tolerance test data in healthy volunteers. J Clin Pharmacol 50:246-256
9. Brubaker PL, Ohayon EL, D'Alessandro LM, Norwich KH (2007) A mathematical model of the oral glucose tolerance test illustrating the effects of the incretins. Ann Biomed Eng 35:1286-1300
10. Dalla Man C, Micheletto F, Sathananthan A, Rizza RA, Vella A, Cobelli C (2010) A model of GLP-1 action on insulin secretion in nondiabetic subjects. Am J Physiol Endocrinol Metab 298:E1115-E1121
11. Salinari S, Bertuzzi A, Mingrone G (2011) Intestinal transit of a glucose bolus and incretin kinetics: a mathematical model with application to the oral glucose tolerance test. Am J Physiol Endocrinol Metab 300:E955-E965
12. Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221-S226
13. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159-E1166
14. American Diabetes Association (1997) Report of the Expert Committee on Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
15. Vardarli I, Arndt E, Deacon CF, Holst JJ, Nauck MA (2013) Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and 'isoglycemic' intravenous glucose. Diabetes 63:663-674
16. Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ (2011) Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 54:10-18
17. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA (2005) Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90:493-500
18. Mari A, Bagger JI, Ferrannini E, Holst JJ, Knop FK, Vilsbøll T (2013) Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes. PLoS One 8:e73154
19. Mari A, Ferrannini E (2008) Beta-cell function assessment from modelling of oral tests: an effective approach. Diabetes Obes Metab 10(Suppl 4):77-87